Skip to main content
MindBio Therapeutics Corp. logo

MindBio Therapeutics Corp. — Investor Relations & Filings

Ticker · MBIO ISIN · CA60256C2076 LEI · 984500489CE405C74C66 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 190 across all filing types
Latest filing 2025-01-21 Regulatory Filings
Country CA Canada
Listing CSE MBIO

About MindBio Therapeutics Corp.

https://mindbiotherapeutics.com/

MindBio Therapeutics Corp. develops and commercializes AI-powered health prediction technologies utilizing proprietary acoustic biomarkers extracted from the human voice. The company's core offering is a comprehensive enterprise platform designed for real-time intoxication and impairment detection, primarily focusing on sobriety verification in safety-critical environments. This platform employs machine learning algorithms to analyze over 140 acoustic parameters, such as jitter, shimmer, and spectral entropy, achieving greater than 88% prediction accuracy in under three seconds. Target markets include zero-tolerance industries like aviation, mining, and construction, requiring scalable, non-invasive fitness-for-duty verification. The technology transforms speech into actionable health intelligence for workforce monitoring and advanced telehealth applications.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 85% confidence The document is a Form 52-109FV2 certification by the CEO for interim filings under NI 52-109, confirming review and fair presentation of the interim financial report and MD&A. It is not the interim report itself (no financials) nor an announcement of report publication, but a mandatory regulatory certificate filing. This fits the fallback category for miscellaneous regulatory filings.
2025-01-21 English
Interim MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled “Management’s Discussion and Analysis” and provides management’s detailed explanation of operations, results of operations, liquidity, capital resources, and forward-looking statements for the six months ended December 31, 2024. This corresponds precisely with the definition of a Management Report (MD&A) rather than a full interim financial report, earnings release, or other category.
2025-01-21 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive set of interim financial statements for Mindbio Therapeutics Corp for the six-month period ending 31 December 2024. It includes a statement of profit or loss, statement of financial position, statement of changes in equity, statement of cash flows, and detailed notes to the financial statements. It explicitly references IAS 34 'Interim Financial Reporting'. As it contains substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2024
2025-01-21 English
News release - English.pdf
Regulatory Filings
2025-01-15 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Annual General Meeting, including agenda items, record date, and proxy voting instructions, which is exactly the kind of material sent to shareholders to solicit their votes. This falls under Proxy Solicitation & Information Statement (Code: PSI).
2024-12-12 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a Form of Proxy solicited by management for the company’s Annual General Meeting, providing instructions for appointing proxyholders and voting on meeting resolutions. This matches the definition of Proxy Solicitation & Information Statement (materials sent to shareholders to request votes).
2024-12-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.